Screener
AngioDynamics ANGO EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by AngioDynamics in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026.
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
| Line item | Year ended May 31, 2026 | Year ended May 31, 2025 | Year ended May 31, 2024 |
|---|---|---|---|
| Income tax expense (benefit) | 442 | (39) | (7,289) |
| Net loss | $(36,742) | $(33,993) | $(184,349) |
| Loss per share | |||
| Basic | $(0.88) | $(0.83) | $(4.59) |
| Diluted | $(0.88) | $(0.83) | $(4.59) |
| Weighted average shares outstanding | |||
| Basic | 41,526 | 40,853 | 40,181 |
| Diluted | 41,526 | 40,853 | 40,181 |
Item 15. Exhibits, Financial Statement Schedules.
FAQ
- What is AngioDynamics's EPS (diluted)?
- AngioDynamics (ANGO) reported EPS (diluted) of -$0.27 in Q1 2026.
- How has AngioDynamics's EPS (diluted) changed year-over-year?
- AngioDynamics's EPS (diluted) decreased by 80.0% year-over-year, from -$0.15 to -$0.27.
- What is the long-term trend for AngioDynamics's EPS (diluted)?
- Over 4 years (2022 to 2026), AngioDynamics's EPS (diluted) has grown at a 6.4% compound annual growth rate (CAGR), from -$0.68 to -$0.87.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about AngioDynamics's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude